Designing Growth Strategies is in our DNA

CAR-T Cell Therapy Market Size, Share & Industry Analysis, By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, and Others), By Indication (Large B-cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma, and Others), By Age Group (Pediatric and Adults), By End User (Hospital-based CAR T-cell Treatment Centers, Standalone Cancer Treatment Centers, and Others), and Regional Forecast, 2026-2034

Last Updated :August 24, 2026 | Format:PDF | Report ID: 108455

 

Request for Customization

man icon
Mail icon
Mail icon
Get 30-60 Hours of FREE Customization on this Report
Company Mapping:

Additional company profiling and benchmarking

Competitive Intelligence:

Advanced competitive landscape assessment

Segment Broadening:

Expanded segment-level coverage

Use-Case Analysis:

Tailored application and end-user evaluation

Extended Study Period:

Extended forecast and historical period

Geographic Granularity:

More detailed regional and country-level insights

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 149